(E)-3-(3-(Benzyloxy)-5-(phenethylcarbamoyl)phenyl)acrylic Acid

ID: ALA4568995

Chembl Id: CHEMBL4568995

PubChem CID: 135304462

Max Phase: Preclinical

Molecular Formula: C25H23NO4

Molecular Weight: 401.46

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)/C=C/c1cc(OCc2ccccc2)cc(C(=O)NCCc2ccccc2)c1

Standard InChI:  InChI=1S/C25H23NO4/c27-24(28)12-11-21-15-22(25(29)26-14-13-19-7-3-1-4-8-19)17-23(16-21)30-18-20-9-5-2-6-10-20/h1-12,15-17H,13-14,18H2,(H,26,29)(H,27,28)/b12-11+

Standard InChI Key:  BMPXIXYIJSWPOS-VAWYXSNFSA-N

Alternative Forms

  1. Parent:

    ALA4568995

    ---

Associated Targets(Human)

AKR1C2 Tchem Aldo-keto reductase family 1 member C2 (639 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKR1C3 Tchem Aldo-keto-reductase family 1 member C3 (1414 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKR1C1 Tchem Aldo-keto reductase family 1 member C1 (475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKR1C4 Tchem Aldo-keto reductase family 1 member C4 (224 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.46Molecular Weight (Monoisotopic): 401.1627AlogP: 4.34#Rotatable Bonds: 9
Polar Surface Area: 75.63Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.45CX Basic pKa: CX LogP: 4.79CX LogD: 1.40
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: -0.39

References

1. Verma K, Zang T, Penning TM, Trippier PC..  (2019)  Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.,  62  (7): [PMID:30836001] [10.1021/acs.jmedchem.9b00090]

Source